Hydroxyurea to lower transcranial Doppler velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort

Haematologica. 2020 Jun;105(6):e272-e275. doi: 10.3324/haematol.2019.231407. Epub 2019 Oct 24.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia, Sickle Cell* / complications
  • Anemia, Sickle Cell* / diagnostic imaging
  • Anemia, Sickle Cell* / drug therapy
  • Blood Flow Velocity
  • Humans
  • Hydroxyurea / therapeutic use
  • Stroke* / etiology
  • Stroke* / prevention & control
  • Uganda
  • Ultrasonography, Doppler, Transcranial

Substances

  • Hydroxyurea